Neeta Somaiah
M.D. Anderson Cancer Center
3
3
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Amir A Jazaeri
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Sandra D'Angelo, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
William Petty
Wake Forest University Health Sciences
Shared therapeutic areas:
Worked with same sponsors:
Show-Li Sun, MD
Astex Pharmaceuticals, Inc.
Shared therapeutic areas:
Thomas Cash, MD, MSc
Emory University
Shared therapeutic areas:
Jordan D. Berlin, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
C.M.L. van Herpen, MD, Phd
UMCN st Radboud
Shared therapeutic areas:
Michael Leahy, MBChB, FRACP, FRCP, FRC Path
Fremantle Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ross Andrew Soo, MBBS
National University Hospital, Singapore
Shared therapeutic areas:
John W Glod, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
All 3 trials loaded